Article Details
Retrieved on: 2024-07-29 14:30:42
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the market opportunities and growth forecasts for treatments targeting spinal muscular atrophy (SMA), highlighting the roles of biotechnology companies and specific drugs like nusinersen and onasemnogene abeparvovec. It ties into technology marketing by showcasing strategic business and marketing initiatives in the biotech sector.
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here